Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PARP10 is highly expressed and associated with inferior outcomes in acute myeloid leukemia.

Aging - 27 Jul 2023

Wang Ling, Jiang Chuang, Hu Dandan

Abstract excerpt

Acute myeloid leukemia is a heterogeneous disease of the hematopoietic system, which possesses a poor prognosis; thus, the identification of novel molecular markers is urgently needed to better define the risk stratification and optimize treatment therapies for this disease. Here, we investigated the roles of the PARP family genes in AML by analyzing their mRNA expression profiles and their association with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Hematopoietic Stem Cell Transplantation
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Multivariate Analysis

Share to Poly(ADP-ribose) Polymerases

Share to Prognosis

Share to Progression-Free Survival

Share to Proto-Oncogene Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 37506247
DOI: 10.18632/aging.204832
PMCID: PMC10415541

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PARP10 is highly expressed and associated with inferior outcomes in acute myeloid leukemia.PMID 37506247Read ↗

High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effectsSemantic proximity Read ↗

Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cellsSemantic proximity Read ↗

PARP-1 Overexpression as an Independent Prognostic Factor in Adult Non-M3 Acute Myeloid Leukemia.Semantic proximity Read ↗

Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemiaSemantic proximity Read ↗

Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cellsSemantic proximity Read ↗

Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemiaSemantic proximity Read ↗

High HSPA8 expression predicts adverse outcomes of acute myeloid leukemia.Semantic proximity Read ↗

Alternative splicing events show high prognostic values and indicate potential core genes in acute myeloid leukemiaSemantic proximity Read ↗

PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndromeSemantic proximity Read ↗

Alternative splicing analysis showed the splicing factor polypyrimidine tract-binding protein 1 as a potential target in acute myeloid leukemia therapySemantic proximity Read ↗

PARP Inhibitors and Myeloid Neoplasms: A Double-Edged SwordSemantic proximity Read ↗

Prognostic value of circular RNAs expression and correlation with clinicopathological features in acute myeloid leukemia; a comprehensive systematic review and meta-analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.